{"id":"https://openalex.org/W2020332328","doi":"https://doi.org/10.1093/eurjhf/hfs205","title":"Baseline and Serial Measurements of Galectin-3 in Patients with Heart Failure: Relationship to Prognosis and Effect of Treatment with Valsartan in the Val-HeFT","display_name":"Baseline and Serial Measurements of Galectin-3 in Patients with Heart Failure: Relationship to Prognosis and Effect of Treatment with Valsartan in the Val-HeFT","alternate_titles":[],"publication_year":2013,"publication_date":"2013-01-05","ids":{"openalex":"https://openalex.org/W2020332328","doi":"https://doi.org/10.1093/eurjhf/hfs205","mag":"2020332328","pmid":"https://pubmed.ncbi.nlm.nih.gov/23291728"},"language":"en","primary_location":{"id":"doi:10.1093/eurjhf/hfs205","doi":"https://doi.org/10.1093/eurjhf/hfs205","is_oa":false,"landing_page_url":"https://doi.org/10.1093/eurjhf/hfs205","pdf_url":null,"source":{"id":"https://openalex.org/S87609158","display_name":"European Journal of Heart Failure","issn_l":"1388-9842","issn":["1388-9842","1879-0844"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Heart Failure","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2020332328"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5007353842","display_name":"Inder S. Anand","orcid":"https://orcid.org/0000-0003-1308-4963","observed_orcids":["https://orcid.org/0000-0003-1308-4963"]},"institutions":[{"id":"https://openalex.org/I130238516","display_name":"University of Minnesota","ror":"https://ror.org/017zqws13","country_code":"US","type":"education","lineage":["https://openalex.org/I130238516"]},{"id":"https://openalex.org/I4210140408","display_name":"Minneapolis VA Medical Center","ror":"https://ror.org/032b8d361","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I4210117246","https://openalex.org/I4210117924","https://openalex.org/I4210140408"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Inder S. Anand","raw_affiliation_strings":["University of Minnesota , Minneapolis, MN, USA","VA Medical Center , Minneapolis, MN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Minnesota , Minneapolis, MN, USA","institution_ids":["https://openalex.org/I130238516"]},{"raw_affiliation_string":"VA Medical Center , Minneapolis, MN, USA","institution_ids":["https://openalex.org/I4210140408"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089352060","display_name":"Thomas S. Rector","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I130238516","display_name":"University of Minnesota","ror":"https://ror.org/017zqws13","country_code":"US","type":"education","lineage":["https://openalex.org/I130238516"]},{"id":"https://openalex.org/I4210140408","display_name":"Minneapolis VA Medical Center","ror":"https://ror.org/032b8d361","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I4210117246","https://openalex.org/I4210117924","https://openalex.org/I4210140408"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thomas S. Rector","raw_affiliation_strings":["University of Minnesota , Minneapolis, MN, USA","VA Medical Center , Minneapolis, MN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Minnesota , Minneapolis, MN, USA","institution_ids":["https://openalex.org/I130238516"]},{"raw_affiliation_string":"VA Medical Center , Minneapolis, MN, USA","institution_ids":["https://openalex.org/I4210140408"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111955119","display_name":"Michael A. Kuskowski","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140408","display_name":"Minneapolis VA Medical Center","ror":"https://ror.org/032b8d361","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I4210117246","https://openalex.org/I4210117924","https://openalex.org/I4210140408"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Kuskowski","raw_affiliation_strings":["VA Medical Center , Minneapolis, MN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"VA Medical Center , Minneapolis, MN, USA","institution_ids":["https://openalex.org/I4210140408"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010200052","display_name":"Aram S. Adourian","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210125757","display_name":"BG Medicine (United States)","ror":"https://ror.org/02x1cd136","country_code":"US","type":"company","lineage":["https://openalex.org/I4210125757"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aram Adourian","raw_affiliation_strings":["BG Medicine , Waltham, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BG Medicine , Waltham, MA, USA","institution_ids":["https://openalex.org/I4210125757"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077681538","display_name":"Pieter Muntendam","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210125757","display_name":"BG Medicine (United States)","ror":"https://ror.org/02x1cd136","country_code":"US","type":"company","lineage":["https://openalex.org/I4210125757"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pieter Muntendam","raw_affiliation_strings":["BG Medicine , Waltham, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BG Medicine , Waltham, MA, USA","institution_ids":["https://openalex.org/I4210125757"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5018464718","display_name":"Jay N. Cohn","orcid":"https://orcid.org/0000-0003-3434-3135","observed_orcids":["https://orcid.org/0000-0003-3434-3135"]},"institutions":[{"id":"https://openalex.org/I130238516","display_name":"University of Minnesota","ror":"https://ror.org/017zqws13","country_code":"US","type":"education","lineage":["https://openalex.org/I130238516"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jay N. Cohn","raw_affiliation_strings":["University of Minnesota , Minneapolis, MN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Minnesota , Minneapolis, MN, USA","institution_ids":["https://openalex.org/I130238516"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5007353842"],"corresponding_institution_ids":["https://openalex.org/I130238516","https://openalex.org/I4210140408"],"apc_list":{"value":5300,"currency":"USD","value_usd":5300},"apc_paid":null,"fwci":15.1274,"has_fulltext":false,"cited_by_count":172,"citation_normalized_percentile":{"value":0.99344132,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":96,"max":100},"biblio":{"volume":"15","issue":"5","first_page":"511","last_page":"518"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10198","display_name":"Heart Failure Treatment and Management","score":0.8349999785423279,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10198","display_name":"Heart Failure Treatment and Management","score":0.8349999785423279,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12387","display_name":"Galectins and Cancer Biology","score":0.13490000367164612,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11962","display_name":"Cardiac Fibrosis and Remodeling","score":0.004900000058114529,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/galectin-3","display_name":"galectin-3","score":1.0},{"id":"https://openalex.org/keywords/heart-failure","display_name":"heart failure","score":0.9980000257492065},{"id":"https://openalex.org/keywords/valsartan","display_name":"valsartan","score":0.9879999756813049},{"id":"https://openalex.org/keywords/val-heft-trial","display_name":"Val-HeFT trial","score":0.9279999732971191},{"id":"https://openalex.org/keywords/prognosis","display_name":"prognosis","score":0.6520000100135803},{"id":"https://openalex.org/keywords/all-cause-mortality","display_name":"all-cause mortality","score":0.8840000033378601},{"id":"https://openalex.org/keywords/hospitalization","display_name":"hospitalization","score":0.6340000033378601},{"id":"https://openalex.org/keywords/renal-dysfunction","display_name":"renal dysfunction","score":0.6880000233650208},{"id":"https://openalex.org/keywords/estimated-glomerular-filtration-rate","display_name":"estimated glomerular filtration rate","score":0.9369999766349792},{"id":"https://openalex.org/keywords/nt-probnp","display_name":"NT-proBNP","score":0.9459999799728394},{"id":"https://openalex.org/keywords/biomarkers","display_name":"biomarkers","score":0.5989999771118164},{"id":"https://openalex.org/keywords/angiotensin-receptor-blockers","display_name":"angiotensin receptor blockers","score":0.7269999980926514}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9179555773735046},{"id":"https://openalex.org/C2777387769","wikidata":"https://www.wikidata.org/wiki/Q155472","display_name":"Valsartan","level":3,"score":0.8879333734512329},{"id":"https://openalex.org/C2776336362","wikidata":"https://www.wikidata.org/wiki/Q18028529","display_name":"Galectin-3","level":2,"score":0.7763445377349854},{"id":"https://openalex.org/C2778198053","wikidata":"https://www.wikidata.org/wiki/Q181754","display_name":"Heart failure","level":2,"score":0.7655044794082642},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.6695277690887451},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.643356204032898},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.5681883692741394},{"id":"https://openalex.org/C159641895","wikidata":"https://www.wikidata.org/wiki/Q108377937","display_name":"Renal function","level":2,"score":0.5144839286804199},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.13405492901802063}],"mesh":[{"descriptor_ui":"D000068756","descriptor_name":"Valsartan","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006333","descriptor_name":"Heart Failure","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D006333","descriptor_name":"Heart Failure","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006333","descriptor_name":"Heart Failure","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D006760","descriptor_name":"Hospitalization","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013777","descriptor_name":"Tetrazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014633","descriptor_name":"Valine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D014633","descriptor_name":"Valine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D015331","descriptor_name":"Cohort Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016016","descriptor_name":"Proportional Hazards Models","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D037502","descriptor_name":"Galectin 3","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D047228","descriptor_name":"Angiotensin II Type 1 Receptor Blockers","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1093/eurjhf/hfs205","doi":"https://doi.org/10.1093/eurjhf/hfs205","is_oa":false,"landing_page_url":"https://doi.org/10.1093/eurjhf/hfs205","pdf_url":null,"source":{"id":"https://openalex.org/S87609158","display_name":"European Journal of Heart Failure","issn_l":"1388-9842","issn":["1388-9842","1879-0844"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Heart Failure","raw_type":"journal-article"},{"id":"pmid:23291728","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23291728","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European journal of heart failure","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":20,"referenced_works":["https://openalex.org/W59799898","https://openalex.org/W70693205","https://openalex.org/W1969343364","https://openalex.org/W2014097940","https://openalex.org/W2015404118","https://openalex.org/W2026515462","https://openalex.org/W2048178709","https://openalex.org/W2050227484","https://openalex.org/W2050865773","https://openalex.org/W2055864845","https://openalex.org/W2056893352","https://openalex.org/W2079689556","https://openalex.org/W2090158969","https://openalex.org/W2091607902","https://openalex.org/W2102815431","https://openalex.org/W2104402487","https://openalex.org/W2123248199","https://openalex.org/W2135164569","https://openalex.org/W2144426613","https://openalex.org/W2166805849"],"related_works":["https://openalex.org/W2139571734","https://openalex.org/W2001417242","https://openalex.org/W2050227484","https://openalex.org/W4396617697","https://openalex.org/W2770489136","https://openalex.org/W2378873319","https://openalex.org/W2015404118","https://openalex.org/W1969461232","https://openalex.org/W2043586033"],"abstract_inverted_index":{"AIMS:":[0],"This":[1],"study":[2],"was":[3,26,86,169,184,266,274],"conducted":[4],"to":[5,60],"determine":[6],"whether":[7],"galectin-3,":[8,287],"a":[9,13,73,185,205,240,277],"\u03b2-galactoside-binding":[10],"lectin,":[11],"plays":[12],"role":[14],"in":[15,46,109,117,152,178,209,213,227,239,260,279,283,290],"the":[16,47,90,95,98,115,130,176,195,219,232,264],"pathogenesis":[17],"of":[18,69,92,97,132,166,175,197,222,243,295],"heart":[19],"failure":[20],"(HF).":[21],"METHODS":[22],"AND":[23],"RESULTS:":[24],"Galectin-3":[25,53,235,256],"measured":[27],"at":[28,55,181],"baseline":[29,56,84,120,148,192],"(n":[30,36,43],"=":[31,37,44,189],"1650),":[32],"after":[33,40,144],"4":[34,122],"months":[35,42,123],"1346),":[38],"and":[39,121,126,139,149,161,194,253,263],"12":[41],"1097)":[45],"Valsartan":[48,203,272],"Heart":[49],"Failure":[50],"Trial":[51],"(Val-HeFT).":[52],"levels":[54,64,168,180,217,230,236,294],"ranged":[57],"from":[58],"4.8":[59],"53":[61],"ng/mL.":[62],"Higher":[63],"were":[65,113,124],"associated":[66,88,128,268,275],"with":[67,89,129,215,229,245,249,269,276,285,292],"features":[68],"worse":[70,270],"HF.":[71,105,202],"In":[72],"fully":[74],"adjusted":[75],"Cox":[76],"regression":[77],"model":[78],"comprising":[79],"23":[80],"other":[81],"prognostic":[82],"variables,":[83],"galectin-3":[85,110,118,167,179,193,216],"not":[87,226,289],"risks":[91,131],"all-cause":[93,134],"mortality,":[94,135],"composite":[96],"first":[99,136],"morbid":[100,137],"event,":[101,138],"or":[102],"hospitalization":[103],"for":[104,141,146,173,201,211,281],"However,":[106],"when":[107],"changes":[108,151],"over":[111,258],"time":[112,259],"examined,":[114],"increases":[116],"between":[119,191],"independently":[125,267],"significantly":[127],"subsequent":[133],"hospitalizations":[140,200,210,280],"HF,":[142,246],"even":[143],"adjusting":[145],"all":[147,153],"concurrent":[150],"variables":[154],"including":[155],"estimated":[156],"glomerular":[157],"filtration":[158],"rate":[159],"(eGFR)":[160],"NT-proBNP.":[162],"The":[163],"strongest":[164],"correlate":[165],"eGFR,":[170],"which":[171],"accounted":[172],"20%":[174],"variability":[177],"baseline.":[182],"There":[183],"significant":[186,206],"interaction":[187],"(P":[188],"0.03)":[190],"effect":[196],"valsartan":[198],"on":[199],"caused":[204],"44%":[207],"reduction":[208,278],"HF":[212,252,282],"patients":[214,228,244,284],"below":[218],"median":[220],"level":[221],"16.2":[223],"ng/mL,":[224],"but":[225,288],"above":[231],"median.":[233],"CONCLUSIONS:":[234],"are":[237],"elevated":[238],"substantial":[241],"proportion":[242],"particularly":[247],"those":[248,291],"more":[250],"severe":[251],"renal":[254],"dysfunction.":[255],"increased":[257],"this":[261],"cohort,":[262],"increase":[265],"outcomes.":[271],"use":[273],"low":[286],"higher":[293],"galectin-3.":[296]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2020332328","counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":8},{"year":2023,"cited_by_count":7},{"year":2022,"cited_by_count":13},{"year":2021,"cited_by_count":10},{"year":2020,"cited_by_count":8},{"year":2019,"cited_by_count":10},{"year":2018,"cited_by_count":13},{"year":2017,"cited_by_count":22},{"year":2016,"cited_by_count":26},{"year":2015,"cited_by_count":20},{"year":2014,"cited_by_count":19},{"year":2013,"cited_by_count":8}],"updated_date":"2026-11-18T13:11:19.462570","created_date":"2016-06-24T00:00:00"}
